-
Články
- Časopisy
- Kurzy
- Témy
- Kongresy
- Videa
- Podcasty
malERA: An updated research agenda for malaria elimination and eradication
The malERA Refresh Consultative Panel on Health Systems and Policy Research summarize a research and development agenda to accelerate malaria elimination and eradicate globally.
Vyšlo v časopise: malERA: An updated research agenda for malaria elimination and eradication. PLoS Med 14(11): e32767. doi:10.1371/journal.pmed.1002456
Kategorie: Collection Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002456Souhrn
The malERA Refresh Consultative Panel on Health Systems and Policy Research summarize a research and development agenda to accelerate malaria elimination and eradicate globally.
Zdroje
1. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, et al. A research agenda to underpin malaria eradication. PLoS Med. 2011;8(1):e1000406. doi: 10.1371/journal.pmed.1000406 21311579
2. World Health Organization. Global technical strategy for malaria 2016–2030. Geneva: WHO; 2015. Contract No.: 17 March.
3. Roll Back Malaria Partnership. Action and investment to defeat malaria 2016–2030: for a malaria-free world Geneva: WHO; 2015 Available from:http://rollbackmalaria.com/. Date accessed 2017 Nov 1.
4. End malaria 2040. From Aspiration to Action: What Will It Take to End Malaria?; 2016.
5. World Health Organization. WHO Strategic advisory group (SAG) on Malaria. Eradication of malaria, Report by the Secretariat. Geneva; 2017 18.05.2017.
6. World Health Organization. A framework for malaria elimination. Geneva; 2017. Contract No.: ISBN: 978 92 4 151198 8.
7. Melinda French Gates. BMGF Malaria Forum Keynote Address: Bill & Melinda Gates Foundation; 2007 [Prepared remarks by Melinda French Gates, co-chair BMGF]. Available from: https://www.gatesfoundation.org/media-center/speeches/2007/10/melinda-french-gates-malaria-forum. Date accessed 2017 Oct 10.
8. Roberts L, Enserink M. Malaria. Did they really say… eradication? Science. 2007;318(5856):1544–5. doi: 10.1126/science.318.5856.1544 18063766
9. World Health Organization. World Malaria Report. Geneva; 2016 13.12.2017. Report No.: ISBN: 978 92 4 151171 1.
10. World Health Organization. Eliminating malaria. Geneva: WHO; 2016, 20 May.
11. World Health Organization. Malaria Policy Advisory Committee meeting report Geneva; 2017, March. Report No.: WHO/HTM/GMP/MPAC/2017.8.
12. malERA Refresh Consultative Panel on Combination Interventions and Modelling. malERA: An updated research agenda on combination interventions and modelling for malaria elimination and eradication. PLoS Med. 2017; 14(11): e1002453. doi: 10.1371.journal.pmed.1002453
13. MESA Track database [Internet]. [cited 2017]. Available from: http://www.malariaeradication.org/mesa-track. Date accessed 2017 Oct 10.
14. World Health Organization. WHO malaria terminology. Geneva: WHO; 2016. Contract No.: 1 October.
15. Epstein JE. Taking a bite out of malaria: controlled human malaria infection by needle and syringe. Am J Trop Med Hyg. 2013;88(1):3–4. doi: 10.4269/ajtmh.2013.12-0715 23303797
16. Mordmuller B, Supan C, Sim KL, Gomez-Perez GP, Ospina Salazar CL, Held J, et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J. 2015;14 : 117. doi: 10.1186/s12936-015-0628-0 25889522
17. Gomez-Perez GP, Legarda A, Munoz J, Sim BK, Ballester MR, Dobano C, et al. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates. Malar J. 2015;14 : 306. doi: 10.1186/s12936-015-0817-x 26245196
18. Dan Strickman. Definition adapted from personal communication. 2017.
19. WHO Alliance for Health Policy and System Research. Systems thinking for health systems strengthening. 2009.
20. Zachariah R, Harries AD, Ishikawa N, Rieder HL, Bissell K, Laserson K, et al. Operational research in low-income countries: what, why, and how? Lancet Infect Dis. 2009;9(11):711–7. doi: 10.1016/S1473-3099(09)70229-4 19850229
21. malERA Consultative Group on Drugs. A research agenda for malaria eradication: drugs. PLoS Med. 2011;8(1):e1000402. doi: 10.1371/journal.pmed.1000402 21311580
22. malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 2011;8(1):e1000398. doi: 10.1371/journal.pmed.1000398 21311586
23. Smith DL, Cohen JM, Chiyaka C, Johnston G, Gething PW, Gosling R, et al. A sticky situation: the unexpected stability of malaria elimination. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2013;368(1623):20120145. doi: 10.1098/rstb.2012.0145 23798693
24. Cohen JM, Smith DL, Cotter C, Ward A, Yamey G, Sabot OJ, et al. Malaria resurgence: a systematic review and assessment of its causes. Malar J. 2012;11 : 122. doi: 10.1186/1475-2875-11-122 22531245
25. Malaria Eradication Scientific Alliance. MESA malERA Refresh [updated 2017. Available from: http://www.malariaeradication.org/. Date accessed 2017 Oct 10.
26. malERA Refresh Consultative Panel on Health Systems and Policy Research. malERA: An updated research agenda for health systems and policy research in malaria elimination and eradication. PLoS Med. 2017; 14(11): e1002454. doi: 10.1371/journal.pmed.1002454
27. malERA Refresh Consultative Panel on Characterising the Reservoir and Measuring Transmission. malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication. PLoS Med. 2017; 14(11): e1002452. doi: 10.1371/journal.pmed.1002452
28. malERA Refresh Consultative Panel on Insecticide and Drug Resistance. malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication. PLoS Med. 2017; 14(11): e1002450. doi: 10.1371/journal.pmed.1002450
29. malERA Refresh Consultative Panel on Tools for Elimination. malERA: An updated research agenda for diagnostics, drugs, vaccines and vector control in malaria elimination and eradication. PLoS Med. 2017; 14(11): e1002455. doi: 10.1371/journal.pmed.1002455
30. Roll Back Malaria Partnership. Global Malaria Action Plan (GMAP) for a malaria-free world. Geneva; 2008.
31. malERA Consultative Group on Health Systems and Operational Research. A research agenda for malaria eradication: health systems and operational research. PLoS Med. 2011;8(1):e1000397. doi: 10.1371/journal.pmed.1000397 21311588
32. malERA Consultative Group on Diagnoses and Diagnostics. A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med. 2011;8(1):e1000396. doi: 10.1371/journal.pmed.1000396 21311583
33. malERA Consultative Group on Vector Control. A research agenda for malaria eradication: vector control. PLoS Med. 2011;8(1):e1000401. doi: 10.1371/journal.pmed.1000401 21311587
34. malERA Refresh Consultative Panel on Basic Science and Enabling Technologies. malERA: An updated research agenda on basic science and enabling technologies in malaria elimination and eradication. PLoS Med. 2017; 14(11): e1002451. doi: 10.1371/journal.pmed.1002451
35. Alere Launches the Alere Malaria Ag P.f, the First-Ever Rapid Test to Screen Malaria Infection in Asymptomatic Individuals [press release]. Alere Inc., 25.04.2017 2017.
36. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526(7572):207–11. doi: 10.1038/nature15535 26375008
37. President’s Malaria Initiative. Entomological Monitoring [Tools and training]. Available from: https://www.pmi.gov/how-we-work/technical-areas/entomological-monitoring. Date accessed 2017 Oct 10.
38. WHO TDR the Special Programme for Research and Training in Tropical Diseases. Capacity strengthening [Available from: http://www.who.int/tdr/capacity/en/. Date accessed 2017 Oct 10.
39. World Health Organization. Global vector control response 2017–2030. Geneva; 2017, May 31.
40. GSK and MMV announce positive headline phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria. [press release]. 12.06.2017 2017.
41. Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, et al. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malar J. 2017;16(1):141. doi: 10.1186/s12936-017-1784-1 28381261
Štítky
Interné lekárstvo
Článek Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort studyČlánek Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
Článok vyšiel v časopisePLOS Medicine
Najčítanejšie tento týždeň
2017 Číslo 11- Pleiotropní účinky statinů na kardiovaskulární systém
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Projekt MedPed
- Jak rozpoznat pacienty s familiární hypercholesterolémií ve své praxi
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
-
Všetky články tohto čísla
- Labour trafficking: Challenges and opportunities from an occupational health perspective
- The end of HIV: Still a very long way to go, but progress continues
- Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study
- Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
- Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study
- Perinatal mortality associated with induction of labour versus expectant management in nulliparous women aged 35 years or over: An English national cohort study
- Core Outcome Set-STAndards for Development: The COS-STAD recommendations
- Closing the gaps in the HIV care continuum
- Association between the 2012 Health and Social Care Act and specialist visits and hospitalisations in England: A controlled interrupted time series analysis
- HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project
- Sexual exploitation of unaccompanied migrant and refugee boys in Greece: Approaches to prevention
- Child sex trafficking in the United States: Challenges for the healthcare provider
- The expanding epidemic of HIV-1 in the Russian Federation
- Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
- Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study
- malERA: An updated research agenda for malaria elimination and eradication
- malERA: An updated research agenda for health systems and policy research in malaria elimination and eradication
- A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study
- Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
- malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication
- Human trafficking and exploitation: A global health concern
- Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
- Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
- Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort
- malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
- HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis
- Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa
- malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication
- Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial
- The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
- HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial
- The US President's Malaria Initiative, transmission and mortality: A modelling study
- Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study
- Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial
- malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication
- malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication
- HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study
- Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis
- Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study
- Measuring success: The challenge of social protection in helping eliminate tuberculosis
- Prospects for passive immunity to prevent HIV infection
- Reaching global HIV/AIDS goals: What got us here, won't get us there
- Evidence-based restructuring of health and social care
- Extreme exploitation in Southeast Asia waters: Challenges in progressing towards universal health coverage for migrant workers
- PLOS Medicine
- Archív čísel
- Aktuálne číslo
- Informácie o časopise
Najčítanejšie v tomto čísle- Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies
- Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
- HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project
- Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
Prihlásenie#ADS_BOTTOM_SCRIPTS#Zabudnuté hesloZadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
- Časopisy